Download or read book Consideration Factors for Developing Successful New Biotechnology Firms in New Zealand written by Diksha Prasad and published by . This book was released on 2015 with total page 210 pages. Available in PDF, EPUB and Kindle. Book excerpt: New biotechnology firms (NBFs) are fundamental to improving New Zealand's economic productivity. However, research has found that relatively few biotechnology firms survive long enough to make significant returns to the economy. Therefore it is imperative to explore the dynamics that affect firm development and growth particularly within the New Zealand context. There is also a need to conduct empirical research specifically at the firm level as much of the empirical research concentrates on broader industry level perspective. This thesis therefore aims to identify factors that NBFs should take into consideration to optimise firm survival and performance. This aim is accomplished by exploring the internal and external challenges that are perceived to impact firm growth and development. A multiple case study research design using semi-structured interviews and secondary data was used to identify these challenges within three New Zealand based biotechnology firms. Semi-structured interviews were conducted with top-level personnel each of whom had first-hand experience of firm development. Secondary data was also collected from company websites, market reports, industry reports, and prominent online new articles. The two sources of data were then triangulated to gain a broader perspective of the challenges at hand. The results indicate that the foremost internal challenges were related to skills and capabilities of the leader or chief executive officer (CEO) in guiding the development of the firm. The ability to harmonise science and business agendas, and integrating teamwork and human capabilities effectively to execute development milestones was another issue. Among other challenges identified were the absence of resource management strategies and risk management tools. Additionally, the external challenges identified suggest New Zealand may be difficult place to develop and grow biotechnology firms. The results lead to recommendations that may enable NBFs to identify strengths and weaknesses in their business strategies and implement measures to ensure effective execution of firm development activities.

Download or read book Key Considerations for a Biotechnology Accelerator written by Kaushala Ratnayake and published by . This book was released on 2017 with total page 72 pages. Available in PDF, EPUB and Kindle. Book excerpt: Many speak of the 21st Century as the Biotech Revolution. Biotechnology accelerator founders feel the industry holds great promise for creating new standards of health, prosperity and sustainability. Biotechnology accelerator programmes are now becoming increasingly prevalent and several are recognised as promising organisations for assisting the development of biotechnology companies. The New Zealand biotechnology industry could potentially benefit from the establishment of a biotechnology accelerator. Adopting a qualitative exploratory methodology, this study explored the key considerations for a biotechnology accelerator within a New Zealand context. This approach was chosen as there is minimal industry research and virtually no academic literature available on biotechnology accelerators. Secondary research reviewed three successful biotechnology accelerators: IndieBio, Biocity Accelerator and OneStart; then fourteen semi-structured interviews were carried out with industry members from the New Zealand biotechnology industry. The secondary findings of the research emphasised collaboration, mentorship, market validation and high intensity learning as keys to existing biotechnology accelerators. Primary findings highlighted the need to expose growing biotechnology companies to experienced individuals, a disconnection across players in the biotechnology industry and the requirement to further educate biotechnology companies on key factors of commercialisation in order develop their sophistication. Exploration of these themes allowed for five key considerations to be shaped, which address the topics of: communal working spaces, mentorship, international networks, commercialisation education and industry endorsement. The Richness, Reach and Receptivity framework provided a useful model to understand the mechanisms through which various aspects of the biotechnology industry and accelerators were affecting developing biotechnology companies. With proposed changes of aligning values and enforcement being added to the framework, the inter-organisational network theory was tailored to the research.

Download or read book The Design Factors for a New Zealand Biotechnology Cluster written by Pooja Bharamappa and published by . This book was released on 2018 with total page 93 pages. Available in PDF, EPUB and Kindle. Book excerpt: The Bay Area biotech cluster, San Diego Biotech and Biovalley are familiar to a majority of the population – even those individuals who are not experts in the field can recall the successes of these communities. All three cases have humble beginnings and over the decades, have created local job opportunities and new business formation ultimately resulting in economic growth. New Zealand biotechnology has world-class potential, ranking number four in overall biotechnology potential according to the Scientific Worldview and outcompeting its Australian counterpart ranked at number five. However, New Zealand's biotech performance still lags behind the city of Melbourne, a city that is usually compared with Auckland due to the similarity in size. ASX-listed biotechnology companies are always valued much higher and are greater in number. How can New Zealand use its potential to increase biotechnology output? This study explores the possibility of implementing a cluster strategy for the New Zealand biotechnology industry. A qualitative exploratory methodology was used to explore the design factors for a NZ biotech cluster. This methodology was appropriate since it is a new mode of inquiry that has previously not been investigated. A conceptual framework was developed from the literature review resulting in three design factors to be considered: specialised or diversified cluster, geographical and relational proximity and cluster formation considerations. Primary findings gathered the perspectives of twelve biotechnology industry members through semi-structured interviews. Secondary findings gathered international cluster examples and critical factors for cluster formation in NZ to support the primary findings. Overall, participants leaned towards a diversified cluster which was in contrast with secondary findings, and a desire for international integration. They also discussed current strengths of the industry in line with critical factors for cluster formation, weaknesses of policy initiatives and how best to engage the private sector in the vision. These three sources of information converged to form important discussions on how such a strategy would apply in the New Zealand biotechnology context, resulting in six recommended design factors: 1) a strategy in favour of specialised clusters, 2) the use of virtual communications for international integration, 3) investing in absorptive capacity, 4) developing strong cluster branding, 5) engaging the private sector as the leader and 6) encouraging the public sector to create initiatives that strive for quality, increased specificity and long-term thinking.

Download or read book Determination of Critical Success Factors for the Development of Biotechnology Clusters written by Markus Fischer and published by GRIN Verlag. This book was released on 2007-09 with total page 37 pages. Available in PDF, EPUB and Kindle. Book excerpt: Essay from the year 2006 in the subject Business economics - Miscellaneous, grade: 1,8, Leipzig Graduate School of Management, course: Innovation, Entrepreneurship and Cluster Development, 11 entries in the bibliography, language: English, abstract: In this paper I am going to discuss factors that initiate and drive the clustering of biotechnology companies. In a first step I will address the question of defining a cluster as such. I then turn to a discussion of believed beneficial outcomes by referring to the works of Porter who claims that among others clusters attract the formation of new businesses and also result in growth of the respective cluster . In the light of ten case studies I will then assess the relevance and impact of critical factors on the creation and development of biotechnology clusters. The findings of the case studies suggest relevant key factors and prerequisites for biotechnological clusters to emerge and to develop. Special emphasis will be placed on the question whether or not the beneficial outcomes of clustering as described by Porter can be confirmed by the case studies and the implications that follow as far as the beneficial outcomes are not being confirmed. The paper will conclude with a theoretical framework that is aimed at capturing the virtuous cycle of biotechnology clusters

Download or read book Beyond Relocation written by Yahn-Zhih (James) Lin and published by . This book was released on 2014 with total page 160 pages. Available in PDF, EPUB and Kindle. Book excerpt: The commercialisation of innovative technologies is a key strategy for nations around the world from which economic prosperity can be derived. High-tech biotechnology is one area which has consistently been the focus of attention by many countries including New Zealand (NZ). Large amounts of investment from limited funds are usually invested by governments to help develop innovative biotechnology companies. When such companies relocate to another country, a sense of loss often ensues, particularly when public funding has been received. This study sought to understand how NZfounded biotech firms, particularly Dedicated Biotech Firms (DBFs), were relocating from NZ followed by an investigation into the main factors involved in their migration offshore through a qualitative research approach. Firm relocation is complex as it no longer necessarily entails moving physical operations from one location to another. Business functions have become increasingly disaggregated due to advances in communication and information technologies allowing partial relocations to occur. This study found that most NZ-founded DBFs undertook partial relocations. The reasons for relocation stemmed from difficulties in commercialising biotech in NZ. Issues of accessing capital to fund operations, availability of the right personnel and NZ's distance from international markets were the main points identified. Most of the factors were seen to converge on a lack of critical mass in NZ's biotech sector and concurrent cost-disadvantages in developing products and entering foreign markets. A requirement for large amounts of capital for commercialisation was found to be the most prominent feature increasing the likelihood of firms relocating from NZ. Recommendations to overcome the financial challenges of commercialising biotech in NZ included a shift in the investment behaviours of large institutional investment entities to buttress the shortage of capital during late development stages. Alternatively, Government investments could be targeted toward less risky biotech ventures leveraging off existing industries in which NZ is already globally competitive such as agriculture and food. Regardless of the changes that may eventuate, NZ's biotech sector still requires significant growth that can only be achieved organically over time.

Download or read book Blending Elements of Success written by Lakshmi Sethuraman and published by . This book was released on 2008 with total page 134 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book An Exploration of the Facilitators and Impediments Influencing the Development of the New Zealand Biotechnology Industry written by Emma-Louise Hunsley and published by . This book was released on 2017 with total page 174 pages. Available in PDF, EPUB and Kindle. Book excerpt: Using qualitative, semi-‐structured interviews of nine participating biotechnology industry members, this case study explored the factors that act as facilitators and impediments to the development of the biotechnology industry in New Zealand. Numerous studies both domestic and international have been conducted to understand the factors that influence biotechnology sector development. It is found that the three major influencers are; factors external to individual firms, factors internal to individual firms and government interventions into the sector. This study investigates these three factors from the perspective of the industry members, and their facilitating or impedimentary impact on the sectors development. This study found that there are numerous internal and external factors influencing the sector, the majority identified were impediments to development, however, some facilitating factors were also identified. These factors included; the shortage of funding and its effects, the shortage of skilled workers, the strength of the networks within the sector, and the impact of taking firms overseas. The majority of these factors were supported by previous studies, however novel findings such as the potential use of New Zealand as a test bed for biotechnology, were also identified. This study’s findings contrasted previous literature with regards to the influence of government. Previous studies found New Zealand’s interventions to be insufficient and in some ways an impediment, however this study found the current interventions to be beneficial to the development of the sector. The identification of factors that influence the development of the biotechnology sector, strategies to overcome or mitigate impediments can be formulated, particularly through use of the facilitating factors.

Download or read book New Zealand Biotechnology Strategy written by New Zealand. Ministry of Research, Science, and Technology and published by . This book was released on 2003-01-01 with total page 40 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book New Zealand Journal of Technology written by and published by . This book was released on 1985 with total page 290 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Research Report written by and published by . This book was released on 1990 with total page 540 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book New Zealand Science Review written by and published by . This book was released on 1985 with total page 324 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Campbell Biology Australian and New Zealand Edition written by Jane B. Reece and published by Pearson Higher Education AU. This book was released on 2015-05-20 with total page 1521 pages. Available in PDF, EPUB and Kindle. Book excerpt: Over nine successful editions, CAMPBELL BIOLOGY has been recognised as the world’s leading introductory biology textbook. The Australian edition of CAMPBELL BIOLOGY continues to engage students with its dynamic coverage of the essential elements of this critical discipline. It is the only biology text and media product that helps students to make connections across different core topics in biology, between text and visuals, between global and Australian/New Zealand biology, and from scientific study to the real world. The Tenth Edition of Australian CAMPBELL BIOLOGY helps launch students to success in biology through its clear and engaging narrative, superior pedagogy, and innovative use of art and photos to promote student learning. It continues to engage students with its dynamic coverage of the essential elements of this critical discipline. This Tenth Edition, with an increased focus on evolution, ensures students receive the most up-to-date, accurate and relevant information.

Download or read book Bibliography of Agriculture written by and published by . This book was released on 1990 with total page 944 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Commercial Biotechnology written by and published by . This book was released on 1984 with total page 28 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book From 9 to Success written by Y.C. Halan and published by Hay House, Inc. This book was released on 2024-01-02 with total page 145 pages. Available in PDF, EPUB and Kindle. Book excerpt: An indispensable guide for anyone aspiring to achieve unparalleled professional excellence. In today’s interconnected world, the job market is evolving at an unprecedented pace, demanding a new set of skills to thrive in a globalised economy. From 9 to Success is a compelling guide that equips individuals with the necessary skills and competencies to stay ahead of the curve in an ever-evolving employment landscape. With insights from various industries and real-life success stories, the book offers a comprehensive roadmap to identify, cultivate, and showcase the skills that are highly sought after in the global job market. From communication and emotional intelligence to mind management, it explores the essential competencies and provides a structured way of developing them in order to excel in diverse professional environments. The book also emphasises the importance of fostering a global mindset that transcends borders and industries and enhances professional effectiveness. So whether you’re a recent graduate, a seasoned professional seeking better career opportunities, or an aspiring entrepreneur, From 9 to Success equips you with the knowledge and strategies to unleash your potential and build a fulfilling and successful career on a global stage.

Download or read book Collaborative Innovation in Drug Discovery written by Rathnam Chaguturu and published by John Wiley & Sons. This book was released on 2014-03-28 with total page 768 pages. Available in PDF, EPUB and Kindle. Book excerpt: Can academia save the pharmaceutical industry? The pharmaceutical industry is at a crossroads. The urgent need for novel therapies cannot stem the skyrocketing costs and plummeting productivity plaguing R&D, and many key products are facing patent expiration. Dr. Rathnam Chaguturu presents a case for collaboration between the pharmaceutical industry and academia that could reverse the industry's decline. Collaborative Innovation in Drug Discovery: Strategies for Public and Private Partnerships provides insight into the potential synergy of basing R&D in academia while leaving drug companies to turn hits into marketable products. As Founder and CEO of iDDPartners, focused on pharmaceutical innovation, Founding president of the International Chemical Biology Society, and Senior Director-Discovery Sciences, SRI International, Dr. Chaguturu has assembled a panel of experts from around the world to weigh in on issues that affect the two driving forces in medical advancement. Gain global perspectives on the benefits and potential issues surrounding collaborative innovation Discover how industries can come together to prevent another "Pharma Cliff" Learn how nonprofits are becoming the driving force behind innovation Read case studies of specific academia-pharma partnerships for real-life examples of successful collaboration Explore government initiatives that help foster cooperation between industry and academia Dr. Chaguturu’s thirty-five years of experience in academia and industry, managing new lead discovery projects and forging collaborative partnerships with academia, disease foundations, nonprofits, and government agencies lend him an informative perspective into the issues facing pharmaceutical progress. In Collaborative Innovation in Drug Discovery: Strategies for Public and Private Partnerships, he and his expert team provide insight into the various nuances of the debate.

Download or read book Innovation in Global Industries written by National Research Council and published by National Academies Press. This book was released on 2008-05-12 with total page 386 pages. Available in PDF, EPUB and Kindle. Book excerpt: The debate over offshoring of production, transfer of technological capabilities, and potential loss of U.S. competitiveness is a long-running one. Prevailing thinking is that "the world is flat"â€"that is, innovative capacity is spreading uniformly; as new centers of manufacturing emerge, research and development and new product development follow. Innovation in Global Industries challenges this thinking. The book, a collection of individually authored studies, examines in detail structural changes in the innovation process in 10 service as well as manufacturing industries: personal computers; semiconductors; flat-panel displays; software; lighting; biotechnology; pharmaceuticals; financial services; logistics; and venture capital. There is no doubt that overall there has been an acceleration in global sourcing of innovation and an emergence of new locations of research capacity and advanced technical skills, but the patterns are highly variable. Many industries and some firms in nearly all industries retain leading-edge capacity in the United States. However, the book concludes that is no reason for complacency about the future outlook. Innovation deserves more emphasis in firm performance measures and more sustained support in public policy. Innovation in Global Industries will be of special interest to business people and government policy makers as well as professors, students, and other researchers of economics, management, international affairs, and political science.